PP2对C6神经胶质瘤细胞增殖和迁移的影响(5)
[18]LEE J G， HEUR M. Interleukin-1 beta enhances cell migration through AP-1 and NF-kappa B pathway-dependent FGF2 expression in human corneal endothelial cells[J]. Biology of the Cell， 2013，105(4)：175-189.
[19]KASPER B， SLEIJFER S， LITIERE S， et al. Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas：subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62 043 and 62 072[J]. Annals of Oncology， 2014，25(3)：719-724.
[20]DEMETRI G D， REICHARDT P， KANG Y K， et al. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID)： an international， multicentre， randomised， placebo-controlled， phase 3 trial[J]. Lancet， 2013，381(9863)：295-302.
[21]MULHALL A， COLE A， PATEL S. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. Cytisine versus nicotine for smoking cessation， and FACED score for non-cystic fibrosis bronchiectasis[J]. American Journal of Respiratory and Critical Care Medicine， 2015，192(2)：249-251.
(本文編辑 马伟平), 百拇医药(唐宁宁 杨艳艳 张杰 刘少燕 于涛)
[19]KASPER B， SLEIJFER S， LITIERE S， et al. Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas：subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62 043 and 62 072[J]. Annals of Oncology， 2014，25(3)：719-724.
[20]DEMETRI G D， REICHARDT P， KANG Y K， et al. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID)： an international， multicentre， randomised， placebo-controlled， phase 3 trial[J]. Lancet， 2013，381(9863)：295-302.
[21]MULHALL A， COLE A， PATEL S. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. Cytisine versus nicotine for smoking cessation， and FACED score for non-cystic fibrosis bronchiectasis[J]. American Journal of Respiratory and Critical Care Medicine， 2015，192(2)：249-251.
(本文編辑 马伟平), 百拇医药(唐宁宁 杨艳艳 张杰 刘少燕 于涛)